Peritoneal dialysis in Herzegovina, Federation of Bosnia and Herzegovina: 18 years of experience from our center

Introduction Due to treatment of end‐stage‐renal‐disease (ESRD), continuous peritoneal dialysis (CAPD) is used in 11% of cases and is associated with several PD‐associated infections. Methods Clinical data on 71 patients with CAPD were evaluated in addition to exit site infections and episodes of ac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Therapeutic apheresis and dialysis 2024-06, Vol.28 (3), p.409-416
Hauptverfasser: Raguž, Fila, Tomić, Monika, Stojčić, Andrea, Tipurić, Manuel, Volarić, Mile, Bevanda, Sanja
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 416
container_issue 3
container_start_page 409
container_title Therapeutic apheresis and dialysis
container_volume 28
creator Raguž, Fila
Tomić, Monika
Stojčić, Andrea
Tipurić, Manuel
Volarić, Mile
Bevanda, Sanja
description Introduction Due to treatment of end‐stage‐renal‐disease (ESRD), continuous peritoneal dialysis (CAPD) is used in 11% of cases and is associated with several PD‐associated infections. Methods Clinical data on 71 patients with CAPD were evaluated in addition to exit site infections and episodes of acute peritonitis (AP). Results There were 39 men and 32 women. Average age was 61 years when we began CAPD and average time spent on CAPD program was 3.35 years. Illness that dominantly caused ESRD was diabetes (23 patients). Exit site infection was mostly caused by S epidermidis‐MRSE and AP was most commonly caused by Staphylococcus sp. group. Most common cause of death was cardiovascular disease. At the end of this study, 9 patients were alive and still on CAPD, 10 were transplanted, 15 switched to HD and 36 died. Conclusion Optimal prevention measures and treatment of infectious complications in CAPD is necessary for better treatment possibilities.
doi_str_mv 10.1111/1744-9987.14097
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2904155072</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2904155072</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2977-eff93e3aa7a737c847ccaba4258a924430aff305e46d63f94ed15aee758bc1bd3</originalsourceid><addsrcrecordid>eNqFkD1PQyEUQInRWL9mN8PoYCs8eOXhpo1VExMddCa3vIvBvEKFVq2Tq3_TX-Kr1cZNlktuzj3DIWSfsx5v3zFXUna1rlSPS6bVGtlabdZXf6U7ZDvnR8aKQgqxSTqi4rxUldgi6RaTn8aA0NDaQzPPPlMf6CWmN3yIzz7AER1ijQmmPgYaHT2LOXigEOq_1Anl1ef7xxwh5QWFr5PWjMEidSmOaZwlajFMMe2SDQdNxr2fuUPuh-d3g8vu9c3F1eD0umsLrVQXndMCBYACJZStpLIWRiCLsgJdSCkYOCdYibJf94XTEmteAqIqq5Hlo1rskMOld5Li0wzz1Ix9ttg0EDDOsik0k7wsmSpa9HiJ2hRzTujMJPkxpLnhzCxCm0VKs8hqvkO3Fwc_8tlojPWK_y3bAuUSePENzv_zmbvT26X4CyWJilo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2904155072</pqid></control><display><type>article</type><title>Peritoneal dialysis in Herzegovina, Federation of Bosnia and Herzegovina: 18 years of experience from our center</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Raguž, Fila ; Tomić, Monika ; Stojčić, Andrea ; Tipurić, Manuel ; Volarić, Mile ; Bevanda, Sanja</creator><creatorcontrib>Raguž, Fila ; Tomić, Monika ; Stojčić, Andrea ; Tipurić, Manuel ; Volarić, Mile ; Bevanda, Sanja</creatorcontrib><description>Introduction Due to treatment of end‐stage‐renal‐disease (ESRD), continuous peritoneal dialysis (CAPD) is used in 11% of cases and is associated with several PD‐associated infections. Methods Clinical data on 71 patients with CAPD were evaluated in addition to exit site infections and episodes of acute peritonitis (AP). Results There were 39 men and 32 women. Average age was 61 years when we began CAPD and average time spent on CAPD program was 3.35 years. Illness that dominantly caused ESRD was diabetes (23 patients). Exit site infection was mostly caused by S epidermidis‐MRSE and AP was most commonly caused by Staphylococcus sp. group. Most common cause of death was cardiovascular disease. At the end of this study, 9 patients were alive and still on CAPD, 10 were transplanted, 15 switched to HD and 36 died. Conclusion Optimal prevention measures and treatment of infectious complications in CAPD is necessary for better treatment possibilities.</description><identifier>ISSN: 1744-9979</identifier><identifier>EISSN: 1744-9987</identifier><identifier>DOI: 10.1111/1744-9987.14097</identifier><identifier>PMID: 38115783</identifier><language>eng</language><publisher>Kyoto, Japan: John Wiley &amp; Sons Australia, Ltd</publisher><subject>acute peritonitis ; Adult ; Aged ; Aged, 80 and over ; Bosnia and Herzegovina - epidemiology ; continuous ambulatory peritoneal dialysis ; end stage renal disease ; exit site infection ; Female ; Humans ; Kidney Failure, Chronic - therapy ; Male ; Middle Aged ; Peritoneal Dialysis, Continuous Ambulatory - adverse effects ; Peritoneal Dialysis, Continuous Ambulatory - methods ; Peritonitis - epidemiology ; Peritonitis - etiology ; Peritonitis - microbiology ; Retrospective Studies</subject><ispartof>Therapeutic apheresis and dialysis, 2024-06, Vol.28 (3), p.409-416</ispartof><rights>2023 International Society for Apheresis and Japanese Society for Apheresis.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2977-eff93e3aa7a737c847ccaba4258a924430aff305e46d63f94ed15aee758bc1bd3</cites><orcidid>0009-0006-4393-9669</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1744-9987.14097$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1744-9987.14097$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38115783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raguž, Fila</creatorcontrib><creatorcontrib>Tomić, Monika</creatorcontrib><creatorcontrib>Stojčić, Andrea</creatorcontrib><creatorcontrib>Tipurić, Manuel</creatorcontrib><creatorcontrib>Volarić, Mile</creatorcontrib><creatorcontrib>Bevanda, Sanja</creatorcontrib><title>Peritoneal dialysis in Herzegovina, Federation of Bosnia and Herzegovina: 18 years of experience from our center</title><title>Therapeutic apheresis and dialysis</title><addtitle>Ther Apher Dial</addtitle><description>Introduction Due to treatment of end‐stage‐renal‐disease (ESRD), continuous peritoneal dialysis (CAPD) is used in 11% of cases and is associated with several PD‐associated infections. Methods Clinical data on 71 patients with CAPD were evaluated in addition to exit site infections and episodes of acute peritonitis (AP). Results There were 39 men and 32 women. Average age was 61 years when we began CAPD and average time spent on CAPD program was 3.35 years. Illness that dominantly caused ESRD was diabetes (23 patients). Exit site infection was mostly caused by S epidermidis‐MRSE and AP was most commonly caused by Staphylococcus sp. group. Most common cause of death was cardiovascular disease. At the end of this study, 9 patients were alive and still on CAPD, 10 were transplanted, 15 switched to HD and 36 died. Conclusion Optimal prevention measures and treatment of infectious complications in CAPD is necessary for better treatment possibilities.</description><subject>acute peritonitis</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Bosnia and Herzegovina - epidemiology</subject><subject>continuous ambulatory peritoneal dialysis</subject><subject>end stage renal disease</subject><subject>exit site infection</subject><subject>Female</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Peritoneal Dialysis, Continuous Ambulatory - adverse effects</subject><subject>Peritoneal Dialysis, Continuous Ambulatory - methods</subject><subject>Peritonitis - epidemiology</subject><subject>Peritonitis - etiology</subject><subject>Peritonitis - microbiology</subject><subject>Retrospective Studies</subject><issn>1744-9979</issn><issn>1744-9987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1PQyEUQInRWL9mN8PoYCs8eOXhpo1VExMddCa3vIvBvEKFVq2Tq3_TX-Kr1cZNlktuzj3DIWSfsx5v3zFXUna1rlSPS6bVGtlabdZXf6U7ZDvnR8aKQgqxSTqi4rxUldgi6RaTn8aA0NDaQzPPPlMf6CWmN3yIzz7AER1ijQmmPgYaHT2LOXigEOq_1Anl1ef7xxwh5QWFr5PWjMEidSmOaZwlajFMMe2SDQdNxr2fuUPuh-d3g8vu9c3F1eD0umsLrVQXndMCBYACJZStpLIWRiCLsgJdSCkYOCdYibJf94XTEmteAqIqq5Hlo1rskMOld5Li0wzz1Ix9ttg0EDDOsik0k7wsmSpa9HiJ2hRzTujMJPkxpLnhzCxCm0VKs8hqvkO3Fwc_8tlojPWK_y3bAuUSePENzv_zmbvT26X4CyWJilo</recordid><startdate>202406</startdate><enddate>202406</enddate><creator>Raguž, Fila</creator><creator>Tomić, Monika</creator><creator>Stojčić, Andrea</creator><creator>Tipurić, Manuel</creator><creator>Volarić, Mile</creator><creator>Bevanda, Sanja</creator><general>John Wiley &amp; Sons Australia, Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0006-4393-9669</orcidid></search><sort><creationdate>202406</creationdate><title>Peritoneal dialysis in Herzegovina, Federation of Bosnia and Herzegovina: 18 years of experience from our center</title><author>Raguž, Fila ; Tomić, Monika ; Stojčić, Andrea ; Tipurić, Manuel ; Volarić, Mile ; Bevanda, Sanja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2977-eff93e3aa7a737c847ccaba4258a924430aff305e46d63f94ed15aee758bc1bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>acute peritonitis</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Bosnia and Herzegovina - epidemiology</topic><topic>continuous ambulatory peritoneal dialysis</topic><topic>end stage renal disease</topic><topic>exit site infection</topic><topic>Female</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Peritoneal Dialysis, Continuous Ambulatory - adverse effects</topic><topic>Peritoneal Dialysis, Continuous Ambulatory - methods</topic><topic>Peritonitis - epidemiology</topic><topic>Peritonitis - etiology</topic><topic>Peritonitis - microbiology</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raguž, Fila</creatorcontrib><creatorcontrib>Tomić, Monika</creatorcontrib><creatorcontrib>Stojčić, Andrea</creatorcontrib><creatorcontrib>Tipurić, Manuel</creatorcontrib><creatorcontrib>Volarić, Mile</creatorcontrib><creatorcontrib>Bevanda, Sanja</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Therapeutic apheresis and dialysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raguž, Fila</au><au>Tomić, Monika</au><au>Stojčić, Andrea</au><au>Tipurić, Manuel</au><au>Volarić, Mile</au><au>Bevanda, Sanja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peritoneal dialysis in Herzegovina, Federation of Bosnia and Herzegovina: 18 years of experience from our center</atitle><jtitle>Therapeutic apheresis and dialysis</jtitle><addtitle>Ther Apher Dial</addtitle><date>2024-06</date><risdate>2024</risdate><volume>28</volume><issue>3</issue><spage>409</spage><epage>416</epage><pages>409-416</pages><issn>1744-9979</issn><eissn>1744-9987</eissn><abstract>Introduction Due to treatment of end‐stage‐renal‐disease (ESRD), continuous peritoneal dialysis (CAPD) is used in 11% of cases and is associated with several PD‐associated infections. Methods Clinical data on 71 patients with CAPD were evaluated in addition to exit site infections and episodes of acute peritonitis (AP). Results There were 39 men and 32 women. Average age was 61 years when we began CAPD and average time spent on CAPD program was 3.35 years. Illness that dominantly caused ESRD was diabetes (23 patients). Exit site infection was mostly caused by S epidermidis‐MRSE and AP was most commonly caused by Staphylococcus sp. group. Most common cause of death was cardiovascular disease. At the end of this study, 9 patients were alive and still on CAPD, 10 were transplanted, 15 switched to HD and 36 died. Conclusion Optimal prevention measures and treatment of infectious complications in CAPD is necessary for better treatment possibilities.</abstract><cop>Kyoto, Japan</cop><pub>John Wiley &amp; Sons Australia, Ltd</pub><pmid>38115783</pmid><doi>10.1111/1744-9987.14097</doi><tpages>8</tpages><orcidid>https://orcid.org/0009-0006-4393-9669</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1744-9979
ispartof Therapeutic apheresis and dialysis, 2024-06, Vol.28 (3), p.409-416
issn 1744-9979
1744-9987
language eng
recordid cdi_proquest_miscellaneous_2904155072
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects acute peritonitis
Adult
Aged
Aged, 80 and over
Bosnia and Herzegovina - epidemiology
continuous ambulatory peritoneal dialysis
end stage renal disease
exit site infection
Female
Humans
Kidney Failure, Chronic - therapy
Male
Middle Aged
Peritoneal Dialysis, Continuous Ambulatory - adverse effects
Peritoneal Dialysis, Continuous Ambulatory - methods
Peritonitis - epidemiology
Peritonitis - etiology
Peritonitis - microbiology
Retrospective Studies
title Peritoneal dialysis in Herzegovina, Federation of Bosnia and Herzegovina: 18 years of experience from our center
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T06%3A07%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peritoneal%20dialysis%20in%20Herzegovina,%20Federation%20of%20Bosnia%20and%20Herzegovina:%2018%E2%80%89years%20of%20experience%20from%20our%20center&rft.jtitle=Therapeutic%20apheresis%20and%20dialysis&rft.au=Ragu%C5%BE,%20Fila&rft.date=2024-06&rft.volume=28&rft.issue=3&rft.spage=409&rft.epage=416&rft.pages=409-416&rft.issn=1744-9979&rft.eissn=1744-9987&rft_id=info:doi/10.1111/1744-9987.14097&rft_dat=%3Cproquest_cross%3E2904155072%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2904155072&rft_id=info:pmid/38115783&rfr_iscdi=true